Search Results

There are 6908 results for: content related to: Absence of associations between influenza vaccines and increased risks of seizures, Guillain–Barré syndrome, encephalitis, or anaphylaxis in the 2012–2013 season

  1. You have full text access to this OnlineOpen article
    Prospective influenza vaccine safety surveillance using fresh data in the Sentinel System

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 5, May 2016, Pages: 481–492, Weiling Katherine Yih, Martin Kulldorff, Sukhminder K. Sandhu, Lauren Zichittella, Judith C. Maro, David V. Cole, Robert Jin, Alison Tse Kawai, Meghan A. Baker, Chunfu Liu, Cheryl N. McMahill-Walraven, Mano S. Selvan, Richard Platt, Michael D. Nguyen and Grace M. Lee

    Article first published online : 17 NOV 2015, DOI: 10.1002/pds.3908

  2. Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013–2014 and 2014–2015 seasons

    Pharmacoepidemiology and Drug Safety

    Rongxia Li, Brock Stewart, Michael M. McNeil, Jonathan Duffy, Jennifer Nelson, Alison Tse Kawai, Roger Baxter, Edward A. Belongia and Eric Weintraub

    Article first published online : 1 APR 2016, DOI: 10.1002/pds.3996

  3. You have full text access to this OnlineOpen article
    Near real-time vaccine safety surveillance using electronic health records—a systematic review of the application of statistical methods

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 3, March 2016, Pages: 225–237, Andreia Leite, Nick J. Andrews and Sara L. Thomas

    Article first published online : 28 JAN 2016, DOI: 10.1002/pds.3966

  4. Terms used in patient safety related to medication: a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 799–809, Antonio Pintor-Mármol, María Isabel Baena, Paloma C. Fajardo, Daniel Sabater-Hernández, Loreto Sáez-Benito, María Victoria García-Cárdenas, Narjis Fikri-Benbrahim, Inés Azpilicueta and Maria José Faus

    Article first published online : 8 JUN 2012, DOI: 10.1002/pds.3296

  5. Balancing benefit and risk of medicines: a systematic review and classification of available methodologies

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 7, July 2014, Pages: 667–678, Shahrul Mt-Isa, Christine E. Hallgreen, Nan Wang, Torbjörn Callréus, Georgy Genov, Ian Hirsch, Stephen F. Hobbiger, Kimberley S. Hockley, Davide Luciani, Lawrence D. Phillips, George Quartey, Sinan B. Sarac, Isabelle Stoeckert, Ioanna Tzoulaki, Alain Micaleff, Deborah Ashby and On behalf of the IMI-PROTECT benefit–risk participants

    Article first published online : 13 MAY 2014, DOI: 10.1002/pds.3636

  6. Literature review of visual representation of the results of benefit–risk assessments of medicinal products

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 3, March 2016, Pages: 238–250, Christine E. Hallgreen, Shahrul Mt-Isa, Alfons Lieftucht, Lawrence D. Phillips, Diana Hughes, Susan Talbot, Alex Asiimwe, Gerald Downey, Georgy Genov, Richard Hermann, Rebecca Noel, Ruth Peters, Alain Micaleff, Ioanna Tzoulaki, Deborah Ashby and On behalf of PROTECT Benefit–Risk group

    Article first published online : 2 NOV 2015, DOI: 10.1002/pds.3880

  7. A critical review of methods to evaluate the impact of FDA regulatory actions

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 9, September 2013, Pages: 986–994, Becky A. Briesacher, Stephen B. Soumerai, Fang Zhang, Sengwee Toh, Susan E. Andrade, Joann L. Wagner, Azadeh Shoaibi and Jerry H. Gurwitz

    Article first published online : 12 JUL 2013, DOI: 10.1002/pds.3480

  8. You have free access to this content
    Challenges in the design and analysis of sequentially monitored postmarket safety surveillance evaluations using electronic observational health care data

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue S1, January 2012, Pages: 62–71, Jennifer C. Nelson, Andrea J. Cook, Onchee Yu, Clara Dominguez, Shanshan Zhao, Sharon K. Greene, Bruce H. Fireman, Steven J. Jacobsen, Eric S. Weintraub and Lisa A. Jackson

    Article first published online : 19 JAN 2012, DOI: 10.1002/pds.2324

  9. Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007–2010

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 4, April 2013, Pages: 335–344, Sharon K. Greene, Lingling Li, David K. Shay, Alicia M. Fry, Grace M. Lee, Steven J. Jacobsen, Roger Baxter, Stephanie A. Irving, Michael L. Jackson, Allison L. Naleway, James D. Nordin, Komal J. Narwaney and Tracy A. Lieu

    Article first published online : 5 NOV 2012, DOI: 10.1002/pds.3363

  10. Adverse drug events in patients admitted to an emergency department: an analysis of direct costs

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 2, February 2015, Pages: 176–186, Florian Meier, Renke Maas, Anja Sonst, Andrius Patapovas, Fabian Müller, Bettina Plank-Kiegele, Barbara Pfistermeister, Oliver Schöffski, Thomas Bürkle and Harald Dormann

    Article first published online : 17 JUN 2014, DOI: 10.1002/pds.3663

  11. Design of a score to identify hospitalized patients at risk of drug-related problems

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 9, September 2014, Pages: 923–932, Olatz Urbina, Olivia Ferrández, Santiago Grau, Sonia Luque, Sergi Mojal, Monica Marin-Casino, Javier Mateu-de-Antonio, Alexia Carmona, David Conde-Estévez, Merce Espona, Elena González, Marta Riu and Esther Salas

    Article first published online : 10 MAY 2014, DOI: 10.1002/pds.3634

  12. You have full text access to this OnlineOpen article
    Post-licensure safety surveillance for human papillomavirus-16/18-AS04-adjuvanted vaccine: more than 4 years of experience

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 5, May 2014, Pages: 456–465, Maria-Genalin Angelo, Julia Zima, Fernanda Tavares Da Silva, Laurence Baril and Felix Arellano

    Article first published online : 20 FEB 2014, DOI: 10.1002/pds.3593

  13. Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 6, June 2013, Pages: 623–631, Adriana M. Hung, Christianne L. Roumie, Robert A. Greevy, Xulei Liu, Carlos G. Grijalva, Harvey J. Murff and Marie R. Griffin

    Article first published online : 17 APR 2013, DOI: 10.1002/pds.3432

  14. Variable selection on large case-crossover data: application to a registry-based study of prescription drugs and road traffic crashes

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 2, February 2014, Pages: 140–151, Marta Avalos, Ludivine Orriols, Hélène Pouyes, Yves Grandvalet, Frantz Thiessard, Emmanuel Lagarde and on behalf of the CESIR research group

    Article first published online : 18 OCT 2013, DOI: 10.1002/pds.3539

  15. Disease risk score as a confounder summary method: systematic review and recommendations

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 2, February 2013, Pages: 122–129, Mina Tadrous, Joshua J. Gagne, Til Stürmer and Suzanne M. Cadarette

    Article first published online : 21 NOV 2012, DOI: 10.1002/pds.3377

  16. Terminal illness and the increased mortality risk of conventional antipsychotics in observational studies: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 2, February 2016, Pages: 113–122, Hendrika J. Luijendijk, Niels C. de Bruin, Tessa A. Hulshof and Xander Koolman

    Article first published online : 25 NOV 2015, DOI: 10.1002/pds.3912

  17. Is the Quebec provincial administrative database a valid source for research on chronic non-cancer pain?

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 9, September 2015, Pages: 980–990, Anaïs Lacasse, Mark A. Ware, Marc Dorais, Hélène Lanctôt and Manon Choinière

    Article first published online : 24 JUN 2015, DOI: 10.1002/pds.3820

  18. You have free access to this content
    Evaluating different physician's prescribing preference based instrumental variables in two primary care databases: a study of inhaled long-acting beta2-agonist use and the risk of myocardial infarction

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue S1, March 2016, Pages: 132–141, Md. Jamal Uddin, Rolf H. H. Groenwold, Anthonius de Boer, Ana S. M. Afonso, Paola Primatesta, Claudia Becker, Svetlana V. Belitser, Arno W. Hoes, Kit C. B. Roes and Olaf H. Klungel

    Article first published online : 1 APR 2016, DOI: 10.1002/pds.3860

  19. Electronic healthcare databases for active drug safety surveillance: is there enough leverage?

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 6, June 2012, Pages: 611–621, Preciosa M. Coloma, Gianluca Trifirò, Martijn J. Schuemie, Rosa Gini, Ron Herings, Julia Hippisley-Cox, Giampiero Mazzaglia, Gino Picelli, Giovanni Corrao, Lars Pedersen, Johan van der Lei, Miriam Sturkenboom and on behalf of the EU-ADR consortium

    Article first published online : 8 FEB 2012, DOI: 10.1002/pds.3197

  20. Pediatric post-marketing safety systems in North America: assessment of the current status

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 8, August 2015, Pages: 785–792, Ann W. McMahon, Gerold T. Wharton, Renan Bonnel, Mary DeCelle, Kimberley Swank, Daniela Testoni, Judith U. Cope, Phillip Brian Smith, Eileen Wu and Mary Dianne Murphy

    Article first published online : 22 JUN 2015, DOI: 10.1002/pds.3813

    Corrected by:

    Erratum: Erratum: Pediatric post-marketing safety systems in North America: assessment of the current status

    Vol. 25, Issue 1, 110–111, Article first published online: 8 JAN 2016